Role of theMTHFRpolymorphisms in cancer risk modification and treatment

Methylenetetrahydrofolate Reductase Polymorphisms, Folate, and Cancer Risk: A Paradigm of Gene-Nutrient Interactions in Carcinogenesis

(2010) Young-In Kim   NUTRITION REVIEWS

DNA Promoter Methylation in Breast Tumors: No Association with Genetic Polymorphisms in MTHFR and MTR

(2009) M. H. Tao et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Thymidylate Synthase and Methylenetetrahydrofolate Reductase Gene Polymorphisms and Toxicity to Capecitabine in Advanced Colorectal Cancer Patients

(2008) R. Sharma et al.   CLINICAL CANCER RESEARCH

The methylenetetrahydrofolate reductase C677T mutation induces cell-specific changes in genomic DNA methylation and uracil misincorporation: A possible molecular basis for the site-specific cancer risk modification

(2008) Kyoung-Jin Sohn et al.   INTERNATIONAL JOURNAL OF CANCER

Effect of Folic Acid and B Vitamins on Risk of Cardiovascular Events and Total Mortality Among Women at High Risk for Cardiovascular Disease

(2008) Christine M. Albert et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Influence of MTHFR and RFC1 Polymorphisms on Toxicities During Maintenance Chemotherapy for Childhood Acute Lymphoblastic Leukemia or Lymphoma

(2008) Noriko Shimasaki et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Pharmacogenetic relevance ofMTHFRpolymorphisms

(2008) Giuseppe Toffoli et al.   PHARMACOGENOMICS

Folic acid supplementation inhibits recurrence of colorectal adenomas: A randomized chemoprevention trial

(2008) Richard Jaszewski et al.   WORLD JOURNAL OF GASTROENTEROLOGY